Nisa Investment Advisors
IMNM icon

Nisa Investment Advisors’s Immunome IMNM Stock Holding History

Nisa Investment Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
47,227
-724
-2% -$15.5K ﹤0.01% 786
2026
Q1 		$1.05M Sell
47,951
-32,277
-40% -$718K ﹤0.01% 769
2025
Q4 		$1.72M Sell
80,228
-198
-0.2% -$3.48K 0.01% 671
2025
Q3 		$942K Buy
80,426
+78,200
+3,513% +$778K ﹤0.01% 859
2025
Q2 		$20.7K Buy
2,226
+269
+14% +$2.21K ﹤0.01% 1920
2025
Q1 		$13.2K Buy
1,957
+1,650
+537% +$15.8K ﹤0.01% 2023
2024
Q4 		$3.26K Buy
307
+108
+54% +$1.3K ﹤0.01% 2365
2024
Q3 		$2.91K Buy
+199
New +$2.83K ﹤0.01% 2335

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Nisa Investment Advisors's IMNM Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Immunome (IMNM) stake by 1.5% in Q2 2026, selling an estimated $15.5K and leaving 47,227 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Nisa Investment Advisors first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.72M in Q4 2025. 62 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Nisa Investment Advisors held 47,227 shares of Immunome worth $1M as of Q2 2026.
  • Nisa Investment Advisors sold 724 Immunome shares in Q2 2026, an estimated $15.5K.
  • Immunome made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #786 holding.
  • Nisa Investment Advisors first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Immunome position peaked at $1.72M in Q4 2025.
  • 62 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.